• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MHY1485

CAS No. 326914-06-1

MHY1485 ( MHY-1485 | MHY1485 | MHY 1485 )

产品货号. M14060 CAS No. 326914-06-1

MHY1485 是一种 mTOR 激活剂;通过抑制自噬体和溶酶体之间的融合来抑制自噬过程,从而导致 LC3II 蛋白的积累和自噬体的增大。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥312 有现货
10MG ¥549 有现货
25MG ¥1042 有现货
50MG ¥1739 有现货
100MG ¥2988 有现货
200MG ¥4338 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥377 有现货

生物学信息

  • 产品名称
    MHY1485
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MHY1485 是一种 mTOR 激活剂;通过抑制自噬体和溶酶体之间的融合来抑制自噬过程,从而导致 LC3II 蛋白的积累和自噬体的增大。
  • 产品描述
    MHY1485 is a mTOR activator; inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes.(In Vitro):MHY1485 (10 μM; 4 hours) shows that GCDC-induced autophagic activity is inhibited by upregulating p-mTOR expression and downregulating LC3 and p62 expression in HCC cells.MHY1485 (5 μM; 6 hours) increases the LC3II/LC3I ratio in a dose and time-dependently manner due to presumably inhibited LC3II degradation in rat liver Ac2F cells.MHY1485 (0.5-2 μM; 6 hours) increases the phosphorylation of mTOR at ser2448 and upregulates the level of phosphorylation of 4E-BP1 in a dose-dependently manner in Ac2F cells.(In Vivo):MHY1485 (intraperitoneal injection; 10?mg/kg, 2 days) blocks the autophagy signaling induced by follicle-stimulating hormone (FSH). It increases p-mTOR and p-S6K1 expression levels, whereas LC3 expression shows no marked change compared to that in the control group.
  • 体外实验
    MHY1485 (10 μM; 4 hours) shows that GCDC-induced autophagic activity is inhibited by upregulating p-mTOR expression and downregulating LC3 and p62 expression in HCC cells.MHY1485 (5 μM; 6 hours) increases the LC3II/LC3I ratio in a dose and time-dependently manner due to presumably inhibited LC3II degradation in rat liver Ac2F cells.MHY1485 (0.5-2 μM; 6 hours) increases the phosphorylation of mTOR at ser2448 and upregulates the level of phosphorylation of 4E-BP1 in a dose-dependently manner inAc2F cells. Western Blot Analysis Cell Line:HCC cells Concentration:10 μM Incubation Time:4 hours Result:Upregulated p-mTOR and downregulated LC3 and p62 expression.
  • 体内实验
    MHY1485 (intraperitoneal injection; 10?mg/kg, 2 days) blocks the autophagy signaling induced by follicle-stimulating hormone (FSH).It increases p-mTOR and p-S6K1 expression levels,whereas LC3 expression shows no marked change compared to that in the control group. Animal Model:4-week-old female ICR mice Dosage:10?mg/kg, 2 days Administration:Intraperitoneal injection Result:Suppressed the autophagy level following FSH treatment.?
  • 同义词
    MHY-1485 | MHY1485 | MHY 1485
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    mTOR
  • 受体
    mTOR
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    326914-06-1
  • 分子量
    387.39
  • 分子式
    C17H21N7O4
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: 33 mg/mL (85.18 mM)
  • SMILES
    O=[N+](C1=CC=C(NC2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)[O-]
  • 化学全称
    4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Choi YJ, et al. PLoS One. 2012, 7(8), e43418.
产品手册
关联产品
  • mTOR inhibitor 9b

    mTOR inhibitor 9b is an enzyme inhibitor of protein kinase mTOR he phosphatidylinositol 3-kinase PIK3CA with IC50s of 0.76 nm and 1.262 μM, respectively.mTOR inhibitor 9b possesses anticancer activity and can be used to study leukemia, skin, breast, lung and colon cancers.

  • Sapanisertib

    Sapanisertib (INK-128, MLN0128) 是一种有效的 ATP 竞争性、口服活性双 mTORC1/2 抑制剂,在无细胞测定中 Ki 为 1.4 nM。

  • Y16

    Y16 是一种 G 蛋白偶联 Rho GEF 抑制剂;与 Rhosin/G04 协同作用,抑制 LARG-RhoA 相互作用、RhoA 激活和 RhoA 介导的信号传导功能。